PharmaCyte Biotech Inc (PMCB)

[rudygerner]

"The company said it was now working with other groups to find new tech that could create a barrier around the cells to help protect them from being assaulted by the body’s immune system, a common problem with this type of therapy."

The bioinert properties and the ability to be cryopreserved (for worldwide shipping purposes) and successfully thawed while retaining more than 95% viability is what puts the Cell-in-a-Box® live cell encapsulation technology in a class all by itself.

Those same properties will soon help improve the quality of life, and even save lives, for those suffering from pc and diabetes, while also contributing to the early retirement of some longs here.